CoChat

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index; 3 of the 21 sources its claims cite were checked for support.

A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis

Open access

Abstract

Background: To examine the effectiveness and acceptability of an 8-week individual tailored cognitive behavioural therapy (CBT) intervention for the treatment of depressive symptoms in those newly diagnosed with multiple sclerosis. Methods: The current study presents a pilot, parallel group randomized controlled trial (RCT) with an allocation ratio of 1:1 conducted in a large research and teaching hospital in Melbourne, Australia. 30 individuals with a mean age of 36.93years (SD=9.63) who were newly diagnosed with multiple sclerosis (MS) (X=24.87months, SD=15.61) were randomized to the CBT intervention (n=15) or treatment as usual (TAU) (n=15). The primary outcome was level of depressive symptoms using the Beck Depression Inventory-II (BDI-II). Secondary outcomes were level of anxiety, fatigue and pain impact, sleep quality, coping, acceptance of MS illness, MS related quality of life, social support, and resilience. Tertiary outcomes were acceptability and adherence to the intervention. Results: Large between group treatment effects were found for level of depressive symptoms at post and at 20weeks follow-up (d=1.66-1.34). There were also small to large group treatment effects for level of anxiety, fatigue and pain impact, sleep quality, MS related quality of life, resilience, and social support at post and at 20weeks follow-up (d=0.17-1.63). There were no drop-outs and participants completed all treatment modules. All participants reported the treatment as 'very useful', and most (73.4%) reported that the intervention had addressed their problems 'completely'. Conclusions: These data suggest that the tailored early intervention is appropriate and clinically effective for the treatment of depressive symptoms in those newly diagnosed with MS. A larger RCT comparing the CBT intervention with an active comparative treatment with longer term follow-up and cost effectiveness analyses is warranted. The pilot trial has been retrospectively registered on 28/04/2016 with the ISRCTN registry (trial ID ISRCTN10423371). © 2016 The Author(s).

Overview

CoChat Summary

TL;DR

This pilot 1:1 randomized controlled trial tested an 8-week individualized CBT intervention for people newly diagnosed with MS and found large reductions in depressive symptoms versus treatment as usual at post-treatment and 20 weeks. The intervention was also reported as highly acceptable, with no dropouts and very high satisfaction.

Key findings

  • In 30 participants (15 CBT, 15 TAU), the CBT group had significantly lower BDI-II scores at post-treatment and 20-week follow-up, with between-group effect sizes ranging from d = 1.34 to 1.66.
  • Secondary outcomes favored CBT for fatigue impact and pain effects scores, with significant group differences at post and 20 weeks; reported effect sizes ranged from d = 0.75 to 1.03 for MFIS/PES.
  • CBT also improved MS-related quality of life: significant differences were reported for the MSQOL physical health composite and mental health composite at post and 20 weeks, with effect sizes ranging from d = 0.70 to 1.04 and d = 1.00 to 1.03, respectively.
  • All intervention participants (n = 15) reported the treatment as “very useful,” completed all homework and modules, had a very strong therapeutic alliance, and 100% said they would “definitely” recommend it to a close friend with MS; 73.4% said it addressed their problems “completely.”

Methods

  • Pilot, parallel-group randomized controlled trial with 1:1 allocation to tailored CBT (n = 15) or treatment as usual (n = 15), conducted in a hospital setting in Melbourne, Australia.
  • Included 30 individuals newly diagnosed with MS; all were within 5 years of diagnosis, and the sample had a mean age of 36.93 years (SD 9.63) and mean time since diagnosis of 24.87 months (SD 15.61).
  • Baseline group differences were tested with ANOVAs; post-treatment and 20-week outcomes were tested with ANCOVAs controlling for baseline scores, gender, and ambulation status; effect sizes were calculated with Cohen’s d.

Limitations

  • The paper states it was a preliminary pilot with a small sample size, only two therapists, reliance on self-report measures, a mostly educated and employed sample, and no active comparative intervention.
  • It also states the follow-up was limited to 20 weeks and that treatment fidelity was not monitored by an independent rater and there were no audio recordings for therapist competency ratings.
  • Evident from the text: blinding was not maintained after assignment, and clinicians who delivered the intervention also helped provide assessment questionnaires, which could introduce bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12888-016-1152-7

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

5 tests recomputed · 0 with the reported and recomputed p on opposite sides of .05

Figures

Fig. 1 CONSORT flow chart of participants going through the trial
Fig. 1 CONSORT flow chart of participants going through the trialCC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 8 Not checked · 45 Own results and interpretations

11 more claims

Create a free account to see all 56 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistics that don’t add up

Each reported p-value recomputed from its test statistic and degrees of freedom.

1 of 1

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Doesn’t add upF(1, 29) = 10.54reported p < .001 · recomputed p = .003

    “F(1, 29) = 10.54, p < .001”

  • ConsistentF(1, 29) = 2.95reported p > .05 · recomputed p = .097

    “F(1, 29) = 2.95, p > .05”

  • ConsistentF(1, 29) = 8.2reported p < .01 · recomputed p = .008

    “F(1, 29) = 8.20, p < .01”

  • ConsistentF(1, 29) = 17.97reported p < .001 · recomputed p < .001

    “F(1, 29) = 17.97, p < .001”

  • ConsistentF(1, 29) = 7.7reported p < .01 · recomputed p = .010

    “F(1, 29) = 7.70, p < .01”

5 of 5

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Citations

Cites

Show all 41 references

Research works printed but not linked: 4

  1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
  2. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, LaRocca NG. Multiple sclerosis quality of life inventory: a user’s manual. NY: New York, National Multiple Sclerosis Society; 1997.
  3. Luborsky L, Barber JP, Siqueland L, Johnson S, Najavits LM, Frank A, Daley D. The revised helping alliance questionnaire (HAQ-II). J Psychother Pract Res. 1996;5:260–71.
  4. Cohen J. Statistical power for the behavioural sciences. 2nd ed. Hillsdale: Erlbaum; 1988.

Cited by

See all 50

Metadata

Authors
Kiropoulos, L. A., Kilpatrick, T., Holmes, A., & Threader, J.
Affiliations
  • The Royal Melbourne Hospital (AU)
  • The University of Melbourne (AU)
Corresponding author
Kiropoulos, Litza A.
Venue
BMC Psychiatry
Published
2016-12
Volume
16
Issue
1
Pages
435-435
ISSN
1471-244X (ISSN-L)
OpenAlex
W2560152410
Cited by
50
References
41
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 4
FWCI
2.73
Type
journal article
Language
en
Open access
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders
University of Melbourne Neurosciences and Behavioural Science domain research grant
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
Keywords
multiple sclerosis, depressive symptoms, cognitive behavioral therapy, personalized interventions, newly diagnosed multiple sclerosis, anxiety, fatigue, sleep quality, resilience, social support, quality of life, treatment acceptability, early psychological intervention
MeSH terms
Adaptation, Psychological, Adult, Anxiety, Australia, Cost-Benefit Analysis, Depression, Fatigue, Female, Health Services, Humans, Male, Multiple Sclerosis, Pilot Projects, Psychiatric Status Rating Scales, Quality of Life, Sleep Wake Disorders, Social Support, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis. https://app.cochat.ai/papers/10.1186/s12888-016-1152-7
The paper
Kiropoulos, L. A., Kilpatrick, T., Holmes, A., & Threader, J. (2016). A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis. BMC Psychiatry. https://doi.org/10.1186/s12888-016-1152-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.